相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。被撤回的出版物: Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection (Retracted article. See vol. 15, 2020)
Mohamed K. Hassan et al.
PLOS ONE (2014)
Weekly paclitaxel plus trastuzumab in metastatic breast cancer pretreated with anthracyclines-a phase II multipractice study
Matthias John et al.
BMC CANCER (2012)
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
Mohamed K. Hassan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Efficient Elimination of Cancer Cells by Deoxyglucose-ABT-263/737 Combination Therapy
Ryuji Yamaguchi et al.
PLOS ONE (2011)
DNA repair and synthetic lethality
Gong-she Guo et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2011)
Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction
L. Stingl et al.
BRITISH JOURNAL OF CANCER (2010)
Mitochondrial signaling in cell death via the Bcl-2 family
Brian Leibowitz et al.
CANCER BIOLOGY & THERAPY (2010)
Crossing paths: interactions between the cell death machinery and growth factor survival signals
Gabriela Brumatti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Defining the DNA mismatch repair-dependent apoptotic pathway in primary cells: Evidence for p53-independence and involvement of centrosomal caspase 2
Kelly A. D. Narine et al.
DNA REPAIR (2010)
IAP antagonists: promising candidates for cancer therapy
Raimund Mannhold et al.
DRUG DISCOVERY TODAY (2010)
Targeting Mitochondria for Cancer Therapy
David M. Hockenbery
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2010)
Cellular FLICE-inhibitory protein (c-FLIP) signalling: A key regulator of receptor-mediated apoptosis in physiologic context and in cancer
Marina Bagnoli et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or Oxaliplatin
Tanvi S. Jani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Human Mutations That Confer Paclitaxel Resistance
Shanghua Yin et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Genomic instability - an evolving hallmark of cancer
Simona Negrini et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Cancer Cells Acquire Mitotic Drug Resistance Properties Through Beta I-Tubulin Mutations and Alterations in the Expression of Beta-Tubulin Isotypes
Chun Hei Antonio Cheung et al.
PLOS ONE (2010)
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Devalingam Mahalingam et al.
CANCER TREATMENT REVIEWS (2009)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing
T. R. Wilson et al.
CELL DEATH AND DIFFERENTIATION (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Pepita Gimenez-Bonafe et al.
CURRENT CANCER DRUG TARGETS (2009)
Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
T. R. Wilson et al.
CURRENT CANCER DRUG TARGETS (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members
Tristan Gallenne et al.
JOURNAL OF CELL BIOLOGY (2009)
Expression and biological significance of c-FLIP in human hepatocellular carcinomas
Xilin Du et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Travis W. Day et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Inhibitor of apoptosis proteins in hematological malignancies
S. Fulda
LEUKEMIA (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
DIFFERENTIAL EXPRESSION OF NUDT9 AT DIFFERENT PHASES OF THE MENSTRUAL CYCLE AND IN DIFFERENT COMPONENTS OF NORMAL AND NEOPLASTIC HUMAN ENDOMETRIUM
Ling-Yun Chen et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
Heat shock protein inhibitors, 17-DMAG and KNK437, enhance arsenic trioxide-induced mitotic apoptosis
Yi-Chen Wu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Apoptosis and cancer: the genesis of a research field
Thomas G. Cotter
NATURE REVIEWS CANCER (2009)
Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy
Simone Fulda
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
The life of a cell: apoptosis regulation by the PI3K/PKB pathway
Vincent Duronio
BIOCHEMICAL JOURNAL (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer
Christine L. Hann et al.
CANCER RESEARCH (2008)
NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
Suzanne A. Eccles et al.
CANCER RESEARCH (2008)
Cellular FLICE-like inhibitory protein (c-FLIP): A novel target for cancer therapy
Ahmad R. Safa et al.
CURRENT CANCER DRUG TARGETS (2008)
Targeting the extrinsic apoptosis pathway in cancer
Avi Ashkenazi
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy
Hidemichi Watari et al.
GYNECOLOGIC ONCOLOGY (2008)
Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities
Jessica Plati et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
An oncogene-induced DNA damage model for cancer development
Thanos D. Halazonetis et al.
SCIENCE (2008)
Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer
Emmanuelle Wesarg et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cells
Xiaoping Zhang et al.
CANCER RESEARCH (2007)
c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications
P. Korkolopoulou et al.
HISTOPATHOLOGY (2007)
Lipid rafts and nonrafts mediate tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic and nonapoptotic signals in non-small cell lung carcinoma cells
Jin H. Song et al.
CANCER RESEARCH (2007)
被撤回的出版物: Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation (Retracted article. See vol. 78, pg. 4097, 2018)
Chang-Shi Chen et al.
CANCER RESEARCH (2007)
Interaction of a cyclin E fragment with Ku70 regulates Bax-mediated apoptosis
Suparna Mazumder et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Brian Leber et al.
APOPTOSIS (2007)
Classic and novel roles of p53:: prospects for anticancer therapy
Jose J. Fuster et al.
TRENDS IN MOLECULAR MEDICINE (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex
Hyun Ho Park et al.
CELL (2007)
Clusterin is highly expressed in pancreatic endocrine tumours but not in solid pseudopapillary tumours
N. Mourra et al.
HISTOPATHOLOGY (2007)
STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival
Manik Chatterjee et al.
BLOOD (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
Therapeutic targeting of apoptotic pathways in cancer
Johannes Meiler et al.
CURRENT DRUG TARGETS (2006)
Inhibition of Hsp90 compromises the DNA damage response to radiation
Hideaki Dote et al.
CANCER RESEARCH (2006)
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy
Hideaki Miyake et al.
UROLOGY (2006)
Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities
J. C. Reed
CELL DEATH AND DIFFERENTIATION (2006)
Review of capecitabine as oral treatment of gastric, gastroesophageal, and Esophageal cancers
Jaffer Ajani
CANCER (2006)
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland
Shen Gao et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
Hsf1-mediated stress response can transiently enhance cellular radioresistance
AE Kabakov et al.
RADIATION RESEARCH (2006)
The biology of Ku and its potential oncogenic role in cancer
Charles Gullo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Capecitabine use in geriatric oncology: An analysis of current safety, efficacy, and quality of life data
WB Ershler
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
The RASSF1A tumor suppressor activates Bax via MOAP-1
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Antimyeloma activity of heat shock protein-90 inhibition
CS Mitsiades et al.
BLOOD (2006)
Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer
B Shannan et al.
CELL DEATH AND DIFFERENTIATION (2006)
Histone deacetylase inhibition induces apoptosis in neuroblastoma
C Subramanian et al.
CELL CYCLE (2005)
Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis
Y Takahashi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
BCL-2: found bound and drugged!
A Letai
TRENDS IN MOLECULAR MEDICINE (2005)
Cutting edge: Innate Immunity conferred by B cells is regulated by caspase-8
DR Beisner et al.
JOURNAL OF IMMUNOLOGY (2005)
Antisense clusterin oligodeoxynucleotides increase the response of HER-2 gene amplified breast cancer cells to trastuzumab
A Biroccio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Apoptosis-based therapies for hematologic malignancies
JC Reed et al.
BLOOD (2005)
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity
A Munshi et al.
CLINICAL CANCER RESEARCH (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation
A Sekiyama et al.
IMMUNITY (2005)
Humanin binds and nullifies bid activity by blocking its activation of Bax and Bak
DY Zhai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor
T Criswell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and γ radiation
IS Ayene et al.
MOLECULAR CANCER THERAPEUTICS (2005)
βIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability
K Kamath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors
C Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
M Gleave et al.
WORLD JOURNAL OF UROLOGY (2005)
Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma
D Xie et al.
CANCER (2005)
Heat shock protein 90 (Hsp90) chaperone complex inhibitor, Radicicol, potentiated radiation-induced cell killing in a hormone-sensitive prostate cancer cell line through degradation of the androgen receptor
K Harashima et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2005)
Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts
JL Eiseman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Repair of double-strand DNA breaks by the human nonhomologous DNA end joining pathway - The iterative processing model
YM Ma et al.
CELL CYCLE (2005)
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex
JIJ Leu et al.
NATURE CELL BIOLOGY (2004)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
NF-κB activation in Esophageal adenocarcinoma -: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy
MMM Abdel-Latif et al.
ANNALS OF SURGERY (2004)
Modulation of different clusterin isoforms in human colon tumorigenesis
S Pucci et al.
ONCOGENE (2004)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis
HY Cohen et al.
MOLECULAR CELL (2004)
Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress
IP Trougakos et al.
CANCER RESEARCH (2004)
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis
JE Chipuk et al.
SCIENCE (2004)
ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway
T Ohtsuka et al.
NATURE CELL BIOLOGY (2004)
A dual role of Cyclin E in cell proliferation and apotosis may provide a target for cancer therapy
S Mazumder et al.
CURRENT CANCER DRUG TARGETS (2004)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
Thymidylate synthase: A critical target in cancer therapy?
YM Rustum
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation
JH Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Oncogenic H-ras up-regulates expression of ERCCI to protect cells from platinum-based anticancer agents
CK Youn et al.
CANCER RESEARCH (2004)
Enhanced tumor cell radiosensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin
EEA Bull et al.
CLINICAL CANCER RESEARCH (2004)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Anticancer drug response and expression of molecular marker in early-passage xenotransplanted colon carcinomas
I Fichtner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells
S Fulda et al.
ONCOGENE (2004)
Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer
XP Zhang et al.
CANCER RESEARCH (2004)
Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance
S Tanno et al.
CANCER RESEARCH (2004)
Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation
ÅB Gustafsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human αA- and αB-crystallins bind to Bax and Bcl-XS to sequester their translocation during staurosporine-induced apoptosis
YW Mao et al.
CELL DEATH AND DIFFERENTIATION (2004)
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
SH Kaufmann et al.
ONCOGENE (2003)
Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity
M Woo et al.
NATURE IMMUNOLOGY (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Thymidylate synthase inhibition triggers apoptosis via caspases-8 and-9 in both wild-type and mutant p53 colon cancer cell lines
HHJ Backus et al.
EUROPEAN JOURNAL OF CANCER (2003)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
Clinical update: proteasome inhibitors in hematologic malignancies
P Richardson
CANCER TREATMENT REVIEWS (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
被撤回的出版物: Ku70 suppresses the apoptotic translocation of Bax to mitochondria (Retracted article. See vol 9, pg 480, 2007)
M Sawada et al.
NATURE CELL BIOLOGY (2003)
p53 has a direct apoptogenic role at the mitochondria
M Mihara et al.
MOLECULAR CELL (2003)
Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review
J Kao et al.
CANCER TREATMENT REVIEWS (2003)
Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3
N Sato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation
H Machida et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2003)
Clusterin/Apolipoprotein J in human aging and cancer
IP Trougakos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2002)
The triterpenoid CDDO induces apoptosis in refractory CLL B cells
IM Pedersen et al.
BLOOD (2002)
Heat-shock protein 90, a chaperone for folding and regulation
D Picard
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil
EN Pugacheva et al.
ONCOGENE (2002)
Synergistic induction of apoptosis in human myeloid leukemia cells by phorbol 12-myristate 13-acetate and flavopiridol proceeds via activation of both the intrinsic and tumor necrosis factor-mediated extrinsic cell death pathways
L Cartee et al.
MOLECULAR PHARMACOLOGY (2002)
Basal levels and patterns of anticancer drug-induced activation of nuclear factor-κB (NF-κB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells
SE Chuang et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Proteolytic cleavage of cyclin E kinase activity and amplification leads to inactivation of associated of apoptosis in hematopoietic cells
S Mazumder et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction
JC Byrd et al.
BLOOD (2002)
P53 overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
JT Liang et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
The role of PML in tumor suppression
P Salomoni et al.
CELL (2002)
BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage
RI Yarden et al.
NATURE GENETICS (2002)
Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: Functional implications
YT Tai et al.
EXPERIMENTAL HEMATOLOGY (2002)
Hsp90 inhibitors as novel cancer chemotherapeutic agents
L Neckers
TRENDS IN MOLECULAR MEDICINE (2002)
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Y Shirota et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
The role of dUTPase and uracil-DNA repair in cancer chemotherapy
RD Ladner
CURRENT PROTEIN & PEPTIDE SCIENCE (2001)
Nuclear receptors in cell life and death
L Altucci et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2001)
ASPP proteins specifically stimulate the apoptotic function of p53
Y Samuels-Lev et al.
MOLECULAR CELL (2001)
BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
PB Mullan et al.
ONCOGENE (2001)
The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition
SD Webley et al.
BRITISH JOURNAL OF CANCER (2001)
Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells
D Chauhan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Recognition of cisplatin adducts by cellular proteins
M Kartalou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak
WX Zong et al.
GENES & DEVELOPMENT (2001)
Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death
MC Wei et al.
SCIENCE (2001)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
AS Baldwin
JOURNAL OF CLINICAL INVESTIGATION (2001)
Mechanisms of p53-dependent apoptosis
M Schuler et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma
S Koyama et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma
C Lavarino et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis
B Motyka et al.
CELL (2000)
Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria
YB Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution
Y Ionov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Modulation of Akt kinase activity by binding to Hsp90
S Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
K Oda et al.
CELL (2000)
Overexpression of clusterin in human breast carcinoma
M Redondo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
p21WAF1/Cip1:: more than a break to the cell cycle?
GP Dotto
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2000)
Apoptosis and cancer chemotherapy
G Makin et al.
CELL AND TISSUE RESEARCH (2000)
Dial 9-1-1 for p53: Mechanisms of p53 activation by cellular stress
M Ljungman
NEOPLASIA (2000)
Mitochondrial control of cell death
G Kroemer et al.
NATURE MEDICINE (2000)
Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis
Q Chen et al.
CELL DEATH AND DIFFERENTIATION (2000)
DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation
MJ Difilippantonio et al.
NATURE (2000)
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
A Paradiso et al.
BRITISH JOURNAL OF CANCER (2000)
Genetic analysis of chemoresistance in primary murine lymphomas
CA Schmitt et al.
NATURE MEDICINE (2000)
Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331
SD Webley et al.
BRITISH JOURNAL OF CANCER (2000)
Immunohistochemical analysis of drug resistance-associated proteins in ovarian carcinomas
D Mayr et al.
PATHOLOGY RESEARCH AND PRACTICE (2000)
分享论文
